Literature DB >> 31710666

Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension.

Rahul Kumar1, Claudia Mickael2, Biruk Kassa1, Linda Sanders2, Daniel Hernandez-Saavedra2, Daniel E Koyanagi2, Sushil Kumar3, Steve C Pugliese4, Stacey Thomas5, Jazalle McClendon5, James P Maloney6, William J Janssen5, Kurt R Stenmark3, Rubin M Tuder2, Brian B Graham1.   

Abstract

AIMS: Transforming growth factor-β (TGF-β) signalling is required for chronic hypoxia-induced pulmonary hypertension (PH). The activation of TGF-β by thrombospondin-1 (TSP-1) contributes to the pathogenesis of hypoxia-induced PH. However, neither the cellular source of pathologic TSP-1 nor the downstream signalling pathway that link activated TGF-β to PH have been determined. In this study, we hypothesized that circulating monocytes, which are recruited to become interstitial macrophages (IMs), are the major source of TSP-1 in hypoxia-exposed mice, and TSP-1 activates TGF-β with increased Rho-kinase signalling, causing vasoconstriction. METHODS AND
RESULTS: Flow cytometry revealed that a specific subset of IMs is the major source of pathologic TSP-1 in hypoxia. Intravenous depletion and parabiosis experiments demonstrated that these cells are circulating prior to recruitment into the interstitium. Rho-kinase-mediated vasoconstriction was a major downstream target of active TGF-β. Thbs1 deficient bone marrow (BM) protected against hypoxic-PH by blocking TGF-β activation and Rho-kinase-mediated vasoconstriction.
CONCLUSION: In hypoxia-challenged mice, BM derived and circulating monocytes are recruited to become IMs which express TSP-1, resulting in TGF-β activation and Rho-kinase-mediated vasoconstriction. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammation; Interstitial macrophages; Pulmonary hypertension; Vasoconstriction

Year:  2020        PMID: 31710666      PMCID: PMC7519884          DOI: 10.1093/cvr/cvz304

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.

Authors:  Tetsutaro Nagaoka; Yoshiteru Morio; Nina Casanova; Natalie Bauer; Sarah Gebb; Ivan McMurtry; Masahiko Oka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-09-05       Impact factor: 5.464

Review 2.  RhoA/Rho-Kinase in the Cardiovascular System.

Authors:  Hiroaki Shimokawa; Shinichiro Sunamura; Kimio Satoh
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

3.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 4.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

5.  Three Unique Interstitial Macrophages in the Murine Lung at Steady State.

Authors:  Sophie L Gibbings; Stacey M Thomas; Shaikh M Atif; Alexandra L McCubbrey; A Nicole Desch; Thomas Danhorn; Sonia M Leach; Donna L Bratton; Peter M Henson; William J Janssen; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

6.  A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.

Authors:  Steven C Pugliese; Sushil Kumar; William J Janssen; Brian B Graham; Maria G Frid; Suzette R Riddle; Karim C El Kasmi; Kurt R Stenmark
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

Review 7.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

8.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

9.  Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni.

Authors:  Brian B Graham; Jacob Chabon; Liya Gebreab; Jennifer Poole; Elias Debella; Laura Davis; Takeshi Tanaka; Linda Sanders; Nina Dropcho; Angela Bandeira; R William Vandivier; Hunter C Champion; Ghazwan Butrous; Xiao-Jing Wang; Thomas A Wynn; Rubin M Tuder
Journal:  Circulation       Date:  2013-08-19       Impact factor: 29.690

10.  Transforming growth factor-β enhances Rho-kinase activity and contraction in airway smooth muscle via the nucleotide exchange factor ARHGEF1.

Authors:  Yasin Shaifta; Charles E MacKay; Nneka Irechukwu; Katie A O'Brien; David B Wright; Jeremy P T Ward; Greg A Knock
Journal:  J Physiol       Date:  2017-11-23       Impact factor: 5.182

View more
  8 in total

1.  Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.

Authors:  Nzali V Campbell; Claudia Mickael; Sushil Kumar; Hui Zhang; Ian L Campbell; Austin E Gillen; Caio O Trentin; Katrina Diener; Bifeng Gao; Vitaly O Kheyfets; Sue Gu; Rahul Kumar; Tzu Phang; R Dale Brown; Brian B Graham; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-24       Impact factor: 6.011

2.  Sexual Dimorphism of Dexamethasone as a Prophylactic Treatment in Pathologies Associated With Acute Hypobaric Hypoxia Exposure.

Authors:  Neha Chanana; Tsering Palmo; Kavita Sharma; Rahul Kumar; Bhushan Shah; Sudhanshu Mahajan; Girish M Palleda; Mohit D Gupta; Ritushree Kukreti; Mohammad Faruq; Tashi Thinlas; Brian B Graham; Qadar Pasha
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 3.  Schistosomiasis Pulmonary Arterial Hypertension.

Authors:  Jean Pierre Sibomana; Aloma Campeche; Roberto J Carvalho-Filho; Ricardo Amorim Correa; Helena Duani; Virginia Pacheco Guimaraes; Joan F Hilton; Biruk Kassa; Rahul Kumar; Michael H Lee; Camila M C Loureiro; Sula Mazimba; Claudia Mickael; Rudolf K F Oliveira; Jaquelina S Ota-Arakaki; Camila Farnese Rezende; Luciana C S Silva; Edford Sinkala; Hanan Yusuf Ahmed; Brian B Graham
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

4.  The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.

Authors:  Mehreen Batool; Eva M Berghausen; Mario Zierden; Marius Vantler; Ralph T Schermuly; Stephan Baldus; Stephan Rosenkranz; Henrik Ten Freyhaus
Journal:  Basic Res Cardiol       Date:  2020-11-13       Impact factor: 17.165

Review 5.  ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies.

Authors:  Silvia Redondo-García; Carlos Peris-Torres; Rita Caracuel-Peramos; Juan Carlos Rodríguez-Manzaneque
Journal:  Matrix Biol Plus       Date:  2020-12-30

Review 6.  The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension.

Authors:  Linlin Huang; Hongdie Zhang; Yijun Liu; Yang Long
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

Review 7.  Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective.

Authors:  Thomas Koudstaal; Karin A Boomars; Mirjam Kool
Journal:  J Clin Med       Date:  2020-02-19       Impact factor: 4.241

Review 8.  ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.

Authors:  Tadeu L Montagnoli; Jaqueline S da Silva; Susumu Z Sudo; Aimeé D Santos; Gabriel F Gomide; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2021-06-30       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.